Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 5;13:2887–2897. doi: 10.2147/OTT.S239425

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Yang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

miR-34c enhances the anti-tumor effect of cisplatin on ovarian cancer in vivo. (A) Nude mice were inoculated subcutaneously with miR-34c-LV-transfected SKOV3 cells followed by treatment with cisplatin i.p. twice a week (2 mg/kg). Tumor growth was measured every three days. (B) Expression level of miR-34c in purified tumors was detected by qRT-PCR analysis. (C) MET expression in purified tumors was detected by Western blot analysis.

Notes: Data was expressed as mean±SD. *P < 0.05 vs. empty LV group, ^#P < 0.05 vs. empty LV + cisplatin group.

Abbreviations: MET, hepatocyte growth factor receptor; LV, lentivirus; qRT-PCR, quantitative Real-Time Polymerase Chain Reaction.